Trial Profile
A Phase I/II Study of Adjuvant Prostate Irradiation and Ixabepilone For High Risk Prostate Cancer Post-Prostatectomy.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ixabepilone (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Mar 2019 Status changed to withdrawn prior to enrolment.
- 14 Feb 2019 Status changed from recruiting to discontinued.
- 11 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.